Skip to content

Legal status · United Kingdom

Is Pegcetacoplan legal in the United Kingdom?

Written by Reviewed Sep 2026

ApprovedImmuneStudies in people cited: 4

Direct answer

Yes. Pegcetacoplan is an approved medicine in the United Kingdom. Its legal category is "Licensed for the blood disease only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile.

People given it
1,258
Found nothing
0

Legal category

Licensed for the blood disease only

The whole-body product is approved in Europe for paroxysmal nocturnal haemoglobinuria. The eye shot for geographic atrophy was refused. The European Medicines Agency committee voted against it in June 2024 and upheld that on a second look in September 2024. Its reason: slowing the growth of the damaged patches did not give patients a benefit that mattered to them.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Pegcetacoplan in the United Kingdom at a glance

Legal categoryLicensed for the blood disease only
NoteThe whole-body product is approved in Europe for paroxysmal nocturnal haemoglobinuria. The eye shot for geographic atrophy was refused. The European Medicines Agency committee voted against it in June 2024 and upheld that on a second look in September 2024. Its reason: slowing the growth of the damaged patches did not give patients a benefit that mattered to them.
MHRA approval statusApproved by MHRA for the use on its label
Studies in people4 of 4 sources on the profile
ReviewedSep 2026

The legal category and note come from the Pegcetacoplan profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.

What this means

  • 01

    MHRA has approved Pegcetacoplan for at least one use named on its label. So a proper pharmacy-grade product exists in the United Kingdom, and pharmacies hand it out on prescription.

  • 02

    Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.

  • 03

    Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.

What Pegcetacoplan is

One drug with two unrelated approvals. As Empaveli, a drip under the skin, it treats a rare blood disease called PNH. There it beat the older drug eculizumab, raising haemoglobin by 3.84 g/dL more at 16 weeks. As Syfovre, a shot into the eye, it treats a late form of age-related vision loss. There it slowed the damaged patch from growing by 16 to 22 percent, but sight was no better at 24 months. European regulators refused the eye use for exactly that reason.

Pegcetacoplan is two identical small ring-shaped proteins, joined by a long chain of a plastic-like material called PEG. Most of its weight is the PEG.

How it works: It sticks to C3, and to C3b, a piece of it, and stops C3 being split. That blocks the step shared by all three routes the complement system uses.

Approval history: FDA-approved twice. Empaveli (NDA 215014) was approved 14 May 2021 as a drip under the skin. It is for adults with paroxysmal nocturnal haemoglobinuria, a rare disease where the immune system destroys red blood cells. It is now also approved from age 12 for two rare kidney diseases, C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis. Syfovre (NDA 217171) was approved 17 February 2023 as a shot into the eye. It is for geographic atrophy, a late stage of age-related macular degeneration. The European Medicines Agency refused the geographic atrophy use in 2024.

How MHRA treats this kind of product

Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.

The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Pegcetacoplan on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check MHRA directly

Pegcetacoplan in sport and the military

Whether Pegcetacoplan is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Pegcetacoplan by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Pegcetacoplan in other countries

Frequently asked questions

Is Pegcetacoplan legal in the United Kingdom?

Yes. Pegcetacoplan is an approved medicine in the United Kingdom. Its legal category is "Licensed for the blood disease only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile. Note: The whole-body product is approved in Europe for paroxysmal nocturnal haemoglobinuria. The eye shot for geographic atrophy was refused. The European Medicines Agency committee voted against it in June 2024 and upheld that on a second look in September 2024. Its reason: slowing the growth of the damaged patches did not give patients a benefit that mattered to them.

Can I buy Pegcetacoplan in the United Kingdom?

Only with a prescription. In the United Kingdom, Pegcetacoplan has the legal category "Licensed for the blood disease only". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: The whole-body product is approved in Europe for paroxysmal nocturnal haemoglobinuria. The eye shot for geographic atrophy was refused. The European Medicines Agency committee voted against it in June 2024 and upheld that on a second look in September 2024. Its reason: slowing the growth of the damaged patches did not give patients a benefit that mattered to them.

Is Pegcetacoplan MHRA approved?

Yes, for the use on its label. In the United Kingdom, Pegcetacoplan has the legal category "Licensed for the blood disease only". For comparison, its US FDA status is: FDA-approved twice. Empaveli (NDA 215014) was approved 14 May 2021 as a drip under the skin. It is for adults with paroxysmal nocturnal haemoglobinuria, a rare disease where the immune system destroys red blood cells. It is now also approved from age 12 for two rare kidney diseases, C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis. Syfovre (NDA 217171) was approved 17 February 2023 as a shot into the eye. It is for geographic atrophy, a late stage of age-related macular degeneration. The European Medicines Agency refused the geographic atrophy use in 2024.. On the evidence, 3 completed human trials are cited on its profile.

Related compounds in the United Kingdom

Full research profile

How Pegcetacoplan works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Pegcetacoplan profile

This page is general information about the legal status of Pegcetacoplan in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.